Jardine Matheson to buy Australia’s I-MED at $2.4 billion enterprise value in healthcare push

By Rajasik Mukherjee and Yantoultra Ngui May 25 (Reuters) – Jardine Matheson said on Monday it has agreed to buy Australian medical imaging provider โ€ŒI-MED Radiology Network for a total enterprise value of A$3.4 billion ($2.4 billion), โ€Œadding a major healthcare diagnostics business to the Hong Kong-based group. The storied investment group, whose businesses โ€‹span…


Jardine Matheson to buy Australia’s I-MED at .4 billion enterprise value in healthcare push

By Rajasik Mukherjee and Yantoultra Ngui

May 25 (Reuters) – Jardine Matheson said on Monday it has agreed to buy Australian medical imaging provider โ€ŒI-MED Radiology Network for a total enterprise value of A$3.4 billion ($2.4 billion), โ€Œadding a major healthcare diagnostics business to the Hong Kong-based group.

The storied investment group, whose businesses โ€‹span property, retail, and automotive sectors, said it will buy a 100% stake in I-MED from funds advised by private equity firm Permira and other shareholders.

It said the deal would be funded through cash reserves and debt financing, without giving โ€Œa split.

Jardines said in a โ statement that the purchase includes I-MED’s minority interest in Harrison.ai, which develops radiology AI solutions, and fits with its strategy of โ investing for control in market-leading businesses and expanding into growth areas.

The deal values I-MED at about 11.5 times forecast adjusted EBITDA for the year ending June 2026, โ€‹excluding the โ€‹Harrison.ai stake, Jardines said in its statement. โ€‹EBITDA stands for earnings before โ€Œinterest, taxes, depreciation and amortisation.

The firm said the deal is expected to be neutral to underlying earnings per share in its first full year after closing and accretive thereafter.

“I-MED is already a market leader in radiology today, and we expect the business will expand further in I-MED’s core markets as well as โ€Œnew markets,” Jardines’ CEO Lincoln Pan, who started โ€‹in his role in December, said in the โ€‹statement.

I-MED operates 215 diagnostic imaging โ€‹clinics in Australia and New Zealand and performs more than โ€Œ7 million procedures each year, Jardines โ€‹said. It also provides โ€‹teleradiology, or the remote reading of medical scans, in Australia, New Zealand and the U.S.

The transaction requires regulatory approvals and is expected to close โ€‹later in 2026, Jardines โ€Œsaid.

In January, Jardines completed its buyout of Mandarin Oriental.

($1 = 1.3970 Australian โ€‹dollars)

(Reporting by Rajasik Mukherjee in Bengaluru and Yantoultra Ngui in Singapore; โ€‹Editing by Sherry Jacob-Phillips and John Mair)

Source link